Infectious Disease and Microbiology – Clonorchis sinensis (Opisthorchis sinensis)

Overview

Clonorchis sinensis, commonly called the Chinese liver fluke, is a foodborne trematode helminth that infects the biliary tract. Human infection, known as clonorchiasis, is acquired by eating raw or inadequately cooked freshwater fish containing infective larvae.

Many infections remain asymptomatic for years. Chronic or heavy infection can cause recurrent biliary inflammation, obstruction, cholangitis, and other hepatobiliary complications. Most importantly, chronic C. sinensis infection is an established risk factor for cholangiocarcinoma.

Microbiologic Characteristics

Clonorchis sinensis is a:

• Trematode

• Flatworm

• Foodborne liver fluke

Adult worms primarily inhabit the intrahepatic bile ducts, where they may survive for many years.

Humans acquire infection by ingesting metacercariae encysted within freshwater fish.

Epidemiology

Clonorchiasis is concentrated in East and Southeast Asia.

Important endemic regions include:

• China, particularly southeastern areas

• Korea

• Taiwan

• Vietnam and other parts of Indochina

• Japan historically and in limited settings

Cases outside endemic areas are usually associated with immigration, travel, or consumption of imported raw freshwater fish.

Transmission

The classic route of transmission is:

Raw/undercooked freshwater fish → ingestion of metacercariae → biliary infection

After ingestion, metacercariae excyst in the duodenum and migrate through the ampulla of Vater into the biliary system.

They subsequently mature into adult flukes within the bile ducts.

Life Cycle

A simplified life cycle is:

Eggs in human feces → freshwater snail → cercariae → freshwater fish → metacercariae → human ingestion → adult worms in bile ducts

Humans acquire infection by eating the infected fish rather than through direct person-to-person transmission.

Clinical Manifestations

The clinical severity depends largely on the number of parasites and duration of infection.

Light infections are frequently asymptomatic.

More substantial or chronic infections may produce:

• Right upper quadrant abdominal discomfort

• Dyspepsia

• Nausea

• Hepatomegaly

• Biliary obstruction

• Jaundice

• Recurrent cholangitis

Symptoms may not become apparent until many years after the initial infection.

Obstructive Jaundice

Large numbers of adult worms, together with chronic inflammation and biliary epithelial changes, can interfere with bile flow.

Patients may develop:

• Jaundice

• Dark urine

• Pale stools

• Pruritus

• Elevated cholestatic liver enzymes

Cholangitis

Chronic biliary infection predisposes to recurrent inflammation and secondary bacterial infection of the biliary tree.

Typical manifestations include:

Fever + right upper quadrant pain + jaundice

This represents the classic Charcot triad of acute cholangitis.

Chronic Biliary Disease

Longstanding clonorchiasis can produce:

• Chronic cholangitis

• Bile duct inflammation and fibrosis

• Biliary obstruction

• Pigment stone formation

• Recurrent pyogenic cholangitis

• Pancreatic involvement in some patients

Repeated epithelial injury is particularly important because of its association with malignant transformation.

Cholangiocarcinoma

The most important long-term complication is cholangiocarcinoma, particularly intrahepatic bile duct cancer.

Chronic infection produces prolonged:

Inflammation → epithelial injury → hyperplasia and dysplasia → increased risk of cholangiocarcinoma

Therefore:

Clonorchis sinensis is a major infectious risk factor for cholangiocarcinoma.

This is one of the highest-yield associations for the organism.

Diagnosis

Stool Examination

The principal parasitologic diagnosis is demonstration of characteristic eggs in the stool.

Because parasite burden may be low, examination of concentrated stool specimens improves diagnostic yield.

Multiple stool specimens may be necessary.

Bile Examination

Eggs can also be identified in bile obtained by:

Duodenal aspiration

This approach may be useful when stool examinations are unrevealing despite strong clinical suspicion.

Serology

Serologic assays may provide supportive evidence of infection.

However, availability is limited, particularly outside endemic regions, and serology does not necessarily distinguish active from previous infection as reliably as direct parasite detection.

Imaging

Although not required to identify the parasite directly, hepatobiliary imaging can help evaluate complications.

Ultrasonography, CT, or MRCP may demonstrate:

• Bile duct abnormalities

• Intrahepatic duct dilation

• Biliary obstruction

• Stones

• Cholangitis-related changes

• A mass suspicious for cholangiocarcinoma

Differential Diagnosis

The differential diagnosis of hepatobiliary fluke infection includes:

• Opisthorchis viverrini

• Opisthorchis felineus

• Fasciola hepatica

• Choledocholithiasis

• Recurrent pyogenic cholangitis

• Primary sclerosing cholangitis

• Biliary malignancy

Importantly, both Clonorchis sinensis and Opisthorchis viverrini are strongly associated with cholangiocarcinoma.

Treatment

Praziquantel

The treatment of choice is generally:

Praziquantel

A commonly used regimen is:

25 mg/kg orally three times daily for 2 days

Praziquantel is highly effective against adult liver flukes.

Albendazole

Albendazole can be used as an alternative.

A regimen historically described is:

Albendazole 10 mg/kg/day orally for 7 days

Praziquantel generally remains the preferred treatment when available.

Management of Complications

Patients with significant biliary obstruction or cholangitis may require additional interventions, such as:

• Antibiotic treatment for bacterial cholangitis

• Endoscopic biliary drainage

• Removal of obstructing material or stones

• Surgical management when indicated

Suspicion for cholangiocarcinoma requires dedicated hepatobiliary evaluation.

Prevention

Prevention depends primarily on avoiding viable metacercariae in freshwater fish.

Effective measures include:

• Thoroughly cooking freshwater fish

• Appropriate freezing or processing where validated

• Avoiding raw or inadequately cooked freshwater fish in endemic areas

• Food-safety education

• Sanitation measures that interrupt contamination of freshwater environments

Irradiation can also destroy infective parasites in fish.

High-Yield Clinical Pattern

Patient from East or Southeast Asia

• ●

History of eating raw freshwater fish

• ●

Recurrent cholangitis or obstructive jaundice

→ Think Clonorchis sinensis

Cancer Association

Chronic liver fluke infection

• ●

Biliary tract inflammation

• ●

Bile duct malignancy

→ Think cholangiocarcinoma associated with Clonorchis sinensis

Exam Essentials

Organism: Clonorchis sinensis

Common name: Chinese liver fluke

Type: Trematode helminth

Transmission: Eating raw or undercooked freshwater fish

Infective stage for humans: Metacercariae in fish

Adult location: Intrahepatic bile ducts

Major endemic areas: China, Korea, Taiwan, and parts of Southeast Asia

Disease: Clonorchiasis

Major manifestations: Biliary obstruction, jaundice, and recurrent cholangitis

Major long-term complication: Cholangiocarcinoma

Diagnosis: Eggs in concentrated stool or bile

Treatment of choice: Praziquantel

Alternative: Albendazole

Prevention: Thoroughly cook freshwater fish

Key clinical pearl: The classic association is raw freshwater fish → Clonorchis sinensis → chronic biliary inflammation → cholangiocarcinoma.

Infectious Disease and Microbiology – Citrobacter Species

Overview

Citrobacter species are aerobic Gram-negative bacilli that belong to the Enterobacterales and can cause a variety of opportunistic infections. They are increasingly important as healthcare-associated pathogens, particularly in hospitalized, debilitated, or immunocompromised patients.

The major clinically relevant species include Citrobacter freundii, Citrobacter koseri, and Citrobacter amalonaticus. Of particular importance, C. koseri has a strong association with neonatal meningitis and brain abscess formation.

Microbiologic Characteristics

Citrobacter organisms are Gram-negative bacilli and facultative anaerobes within the Enterobacterales.

Important characteristics include:

• Gram-negative rods

• Facultative anaerobic metabolism

• Growth on routine bacterial culture media

• Environmental and gastrointestinal reservoirs

They may colonize the human gastrointestinal tract without producing disease but can become pathogenic when host defenses are impaired or invasive devices are present.

Epidemiology

Citrobacter infections occur worldwide and have become increasingly recognized as causes of nosocomial infection.

Healthcare-associated disease is particularly associated with:

• Prolonged hospitalization

• Intensive care exposure

• Indwelling urinary catheters

• Central venous catheters

• Recent surgery

• Broad-spectrum antibiotic exposure

• Immunocompromised states

Because Citrobacter can colonize the gastrointestinal tract, infections may arise endogenously or through healthcare-associated transmission.

Clinical Infections

Urinary Tract Infection

Urinary tract infection is a common manifestation, particularly in hospitalized patients and those with urinary instrumentation.

Clinical presentations range from:

• Asymptomatic bacteriuria

• Cystitis

• Complicated UTI

• Pyelonephritis

• Urosepsis

Indwelling urinary catheters are an important predisposing factor.

Pulmonary Infection

Citrobacter can occasionally cause pneumonia, particularly in hospitalized or immunocompromised patients.

Manifestations may include:

• Fever

• Productive cough

• Dyspnea

• Hypoxemia

• Pulmonary infiltrates

Healthcare-associated and ventilator-associated infections are particularly relevant.

Catheter-Associated Bacteremia

Central venous and other intravascular catheters may become colonized and produce bloodstream infection.

Patients may develop:

• Fever and chills

• Persistent bacteremia

• Hypotension

• Sepsis or septic shock

Removal of an infected catheter may be necessary in addition to antimicrobial therapy.

Surgical Wound Infection

Citrobacter species can infect postoperative wounds and other disrupted skin or soft-tissue sites.

Clinical manifestations include:

• Erythema

• Swelling

• Pain

• Purulent drainage

• Wound dehiscence

• Fever

Deep infections may require drainage or surgical debridement in addition to antibiotics.

Neonatal Meningitis

One of the most important clinical associations is:

Citrobacter koseri → neonatal meningitis

C. koseri has a distinctive tendency to cause severe central nervous system infection in neonates and young infants.

Clinical manifestations may include:

• Fever or temperature instability

• Poor feeding

• Irritability

• Lethargy

• Seizures

• Bulging fontanelle

• Altered consciousness

Brain Abscess Formation

A particularly important feature of C. koseri neonatal meningitis is its tendency to produce:

Multiple brain abscesses

This propensity distinguishes C. koseri from many other causes of neonatal bacterial meningitis.

Complications can include:

• Cerebritis

• Multiple cerebral abscesses

• Ventriculitis

• Hydrocephalus

• Seizures

• Long-term neurologic impairment

Therefore, neuroimaging is often important when neonatal Citrobacter meningitis is suspected or confirmed.

Diagnosis

Diagnosis is established by culture of the organism from the affected site.

Depending on the clinical syndrome, specimens may include:

• Urine

• Blood

• Cerebrospinal fluid

• Respiratory specimens

• Wound material

• Abscess fluid

Identification should be followed by antimicrobial susceptibility testing, particularly because resistance patterns can vary substantially.

Antimicrobial Resistance

Resistance is an important consideration in Citrobacter infections.

In particular, C. freundii can possess inducible chromosomal AmpC beta-lactamase, which may confer resistance to several beta-lactam antibiotics.

This means that an isolate can sometimes appear initially susceptible to certain cephalosporins but subsequently develop clinically significant resistance during treatment.

Other resistance mechanisms, including extended-spectrum beta-lactamases and carbapenem resistance, may also occur.

Consequently, treatment of serious infection should be based on:

Species identification + susceptibility testing + infection severity and site

Treatment

Historically active antimicrobial classes include:

• Third-generation cephalosporins

• Antipseudomonal penicillins

• Carbapenems

• Fluoroquinolones

• Aztreonam

• Aminoglycosides

However, because resistance patterns have evolved considerably, these agents should not be assumed to be universally active.

Carbapenems

Agents such as:

• Meropenem

• Imipenem

may be appropriate for severe infections caused by susceptible organisms, particularly when significant beta-lactam resistance is present.

Fluoroquinolones

Fluoroquinolones may be effective against susceptible isolates and can be useful for selected infections, particularly when adequate tissue penetration and an oral treatment option are needed.

Aminoglycosides

An aminoglycoside may have activity against susceptible isolates.

Historically, aminoglycosides have sometimes been added to another active agent in severe Citrobacter infection, although combination therapy is not automatically required for every patient.

Source Control

Antibiotics alone may be insufficient when an infected foreign body or localized collection is present.

Management may therefore include:

• Removal of an infected vascular catheter

• Removal or replacement of an infected urinary catheter

• Drainage of abscesses

• Debridement of infected surgical wounds

High-Yield Clinical Pattern

Neonate

• ●

Gram-negative meningitis

• ●

Multiple cerebral abscesses

→ Strongly consider Citrobacter koseri

Hospital-Acquired Pattern

Hospitalized patient

• ●

Urinary or central venous catheter

• ●

Gram-negative UTI or bacteremia

→ Citrobacter species should be included among possible healthcare-associated Enterobacterales.

Exam Essentials

Genus: Citrobacter

Important species: C. freundii, C. koseri, C. amalonaticus

Microbiology: Gram-negative bacilli, Enterobacterales

Epidemiology: Increasingly important healthcare-associated pathogens

Major infections: UTI, pneumonia, catheter-associated bacteremia, surgical wound infection

Classic neonatal pathogen: C. koseri

Classic complication: Neonatal meningitis with multiple brain abscesses

Diagnosis: Culture with antimicrobial susceptibility testing

Important resistance mechanism: C. freundii may express AmpC beta-lactamase

Potential treatments: Selected according to susceptibility; options may include carbapenems, fluoroquinolones, and other active Gram-negative agents

Source control: Remove infected devices and drain collections when indicated

Key clinical pearl: The association most worth remembering is Citrobacter koseri → neonatal meningitis → multiple brain abscesses, while C. freundii is particularly important for its potential AmpC-mediated antimicrobial resistance.

Infectious Disease and Microbiology – Chrysosporium parvum

Overview

Chrysosporium parvum is a rare filamentous fungal pathogen capable of producing localized or invasive infections in humans. Although disease is uncommon, infections may involve the lungs, bones, paranasal sinuses, heart valves, and, particularly in immunocompromised patients, multiple organ systems.

Microbiologic Characteristics

Chrysosporium parvum is a filamentous fungus (mold).

In infected tissue, it characteristically appears as:

• Hyaline fungal elements

• Septate hyphae

The term hyaline refers to the relatively nonpigmented appearance of the fungal hyphae, distinguishing it from dematiaceous fungi that contain dark pigment.

Epidemiology

The organism has a worldwide distribution, but documented human infections are rare.

Invasive disease is of greatest concern in patients with impaired host defenses, particularly those with substantial immunosuppression.

Clinical Infections

Osteomyelitis

Chrysosporium parvum can rarely infect bone and cause fungal osteomyelitis.

Patients may develop:

• Localized bone pain

• Swelling

• Reduced function

• Chronic inflammatory changes

Diagnosis generally requires culture and examination of infected tissue.

Pulmonary Infection

Pulmonary disease may occur following respiratory acquisition of fungal elements.

Manifestations can include:

• Fever

• Cough

• Dyspnea

• Chest discomfort

• Pulmonary infiltrates

The diagnosis may be particularly challenging in immunocompromised patients because the presentation can resemble other invasive mold infections.

Prosthetic Valve Endocarditis

Rarely, C. parvum may cause prosthetic valve endocarditis.

Possible manifestations include:

• Persistent fever

• Cardiac murmur

• Embolic complications

• Prosthetic valve dysfunction

• Evidence of systemic fungal infection

Fungal prosthetic valve endocarditis represents a serious invasive infection requiring specialist management.

Rhinitis and Sinusitis

The organism may cause rhinitis or fungal sinusitis.

Disease can involve the nasal cavity and paranasal sinuses and may occasionally become locally invasive.

Possible symptoms include:

• Nasal congestion

• Facial pain or pressure

• Nasal discharge

• Headache

Central Nervous System Extension

Sinus infection may rarely extend directly into adjacent structures and involve the central nervous system.

CNS involvement represents a severe complication and may manifest with neurologic abnormalities, altered mental status, headache, seizures, or focal deficits depending on the site of infection.

Disseminated Infection

Immunocompromised patients are at risk for disseminated disease, in which infection spreads beyond its initial site to involve multiple organs.

This manifestation should be considered when a susceptible patient has evidence of invasive mold infection at more than one anatomic site.

Diagnosis

Fungal Culture

The principal diagnostic method is:

Culture of the fungus from an appropriate clinical specimen

Specimens may include:

• Respiratory material

• Sinus specimens

• Bone specimens

• Blood or cardiovascular tissue when appropriate

• Material obtained from other infected sites

Identification of the organism is important because several hyaline molds can have similar appearances in tissue.

Tissue Biopsy

Identification of fungal elements within a tissue biopsy provides important evidence of invasive disease.

Histopathologic examination may demonstrate septate hyaline hyphae invading affected tissue.

Whenever possible, tissue should be submitted for both:

Histopathology + fungal culture

This helps establish tissue invasion while allowing identification of the responsible organism.

Treatment

Amphotericin B

The traditional treatment described for invasive Chrysosporium parvum infection is:

Intravenous amphotericin B

Treatment duration depends on factors such as:

• Site of infection

• Severity of disease

• Degree of immunosuppression

• Clinical and radiologic response

• Ability to achieve surgical source control

Because these infections are rare, treatment should generally be individualized with infectious disease and clinical microbiology input.

Surgical Management

Although not required for every infection, surgical intervention may be important for localized invasive disease, particularly when there is:

• Infected or necrotic bone

• Extensive sinus disease

• CNS extension

• Prosthetic material involvement

• A localized focus that cannot be eradicated medically

Prosthetic valve endocarditis may require combined antifungal and surgical management.

High-Yield Clinical Pattern

Immunocompromised patient

• ●

Pulmonary, sinus, bone, or disseminated fungal infection

• ●

Septate hyaline hyphae in tissue

• ●

Culture identifying Chrysosporium

→ Consider invasive Chrysosporium parvum infection.

Differential Microbiology

When septate hyaline hyphae are identified in tissue, the differential diagnosis includes several other molds, particularly:

• Aspergillus

• Fusarium

• Scedosporium

• Other hyaline molds

Therefore, morphology alone may not reliably establish the species, and culture or molecular identification can be important.

Exam Essentials

Organism: Chrysosporium parvum

Type: Filamentous fungus (mold)

Tissue morphology: Septate hyaline hyphae

Distribution: Worldwide but rare

Major infections: Osteomyelitis, pulmonary infection, sinusitis, and prosthetic valve endocarditis

Severe complication: CNS extension from rhinosinusitis

High-risk population: Immunocompromised patients

Dissemination: Particularly associated with impaired immunity

Diagnosis: Fungal culture and identification in tissue biopsy

Traditional treatment: Intravenous amphotericin B

Key clinical pearl: Chrysosporium parvum should be considered among the uncommon hyaline molds when an immunocompromised patient develops invasive pulmonary, sinus, osseous, or disseminated fungal disease.

Infectious Disease and Microbiology – Chromoblastomycosis Agents

Overview

Chromoblastomycosis, also called chromomycosis or dermatitis verrucosa, is a chronic fungal infection of the skin and subcutaneous tissues caused by several dematiaceous (darkly pigmented) fungi. Infection typically follows traumatic implantation of the fungus into the skin and develops slowly over months to years.

The disease classically produces chronic verrucous or wart-like lesions of the lower extremities, particularly in barefoot agricultural workers living in tropical and subtropical regions.

Causative Species

Several fungi can cause chromoblastomycosis, including:

• Cladophialophora carrionii (formerly Cladosporium carrionii)

• Fonsecaea compacta

• Fonsecaea pedrosoi — the most common cause

• Phialophora verrucosa

• Rhinocladiella aquaspersa

These organisms are environmental fungi associated particularly with soil, vegetation, and decaying plant material.

Microbiologic Characteristics

The causative organisms are dematiaceous filamentous fungi, meaning that their cell walls contain melanin and therefore appear brown or darkly pigmented.

They characteristically form:

• Septate hyphae in culture

• Pigmented fungal elements in infected tissue

• Sclerotic bodies within tissue

The presence of sclerotic bodies is one of the most important diagnostic features of chromoblastomycosis.

Sclerotic Bodies

In tissue, the fungi transform into characteristic thick-walled, brown, rounded structures known as:

Sclerotic bodies

They are also called:

• Medlar bodies

• Muriform bodies

• Copper-penny bodies

They may divide along multiple planes, producing a characteristic appearance resembling copper pennies.

Sclerotic bodies in a chronic verrucous skin lesion are highly characteristic of chromoblastomycosis.

Incubation Period

The exact incubation period is uncertain because the infection progresses very slowly.

It is probably at least several months, and clinically apparent disease may develop long after the initial traumatic inoculation.

Epidemiology

Chromoblastomycosis occurs worldwide but is most prevalent in tropical and subtropical regions, particularly in developing countries.

It is associated strongly with:

• Rural residence

• Agricultural work

• Walking barefoot

• Frequent contact with soil and vegetation

• Minor penetrating injuries from thorns, wood, or plant material

The lower extremities are affected most often because they are particularly vulnerable to traumatic inoculation.

Pathogenesis

Infection usually begins when contaminated plant material or soil causes a small penetrating injury.

The fungus is introduced directly into:

Skin → subcutaneous tissue

The organism then produces a slowly progressive local inflammatory response.

Unlike many invasive fungal infections, chromoblastomycosis commonly occurs in otherwise immunocompetent individuals because infection results primarily from direct traumatic implantation rather than systemic acquisition.

Clinical Manifestations

Chromoblastomycosis is typically a chronic, slowly progressive cutaneous and subcutaneous infection.

The initial lesion may begin as a small papule or nodule at the site of traumatic inoculation.

Over time, it can enlarge and develop into:

• Verrucous plaques

• Warty nodules

• Papillomatous lesions

• Tumor-like masses

• Crusted plaques

Lesions may resemble large warts or cauliflower-like growths.

Typical Location

The most characteristic location is the:

Lower extremity

Feet and legs are especially commonly affected because of exposure to contaminated soil and vegetation.

Other body regions may occasionally become involved following traumatic implantation.

Chronic Disease

Progression is generally slow, often occurring over years.

As lesions enlarge, patients may develop:

• Secondary bacterial infection

• Ulceration

• Fibrosis

• Lymphatic obstruction

• Lymphedema

• Functional impairment

Extensive disease can become difficult to eradicate.

Dissemination

Chromoblastomycosis generally remains localized to the skin and subcutaneous tissues.

Rarely, deeper extension or dissemination can involve:

• Muscle

• Central nervous system

• Lungs

Such invasive disease is unusual.

Diagnosis

Diagnosis depends on demonstrating the characteristic fungal structures in affected tissue and identifying the causative organism by culture.

Histopathology

The classic diagnostic finding is:

Sclerotic bodies

These are brown, thick-walled fungal structures present within infected tissue.

Their appearance is sufficiently characteristic that identifying them in the appropriate clinical setting strongly supports chromoblastomycosis.

Culture

Fungal culture is used to determine the specific causative organism.

Identification depends on:

• Colony morphology

• Pigmentation

• Microscopic morphology

• Characteristic sporulation patterns

Culture is particularly useful because several different dematiaceous fungi can produce the same clinical syndrome.

Differential Diagnosis

Chronic verrucous lesions can resemble several infectious and noninfectious conditions, including:

• Sporotrichosis

• Mycetoma

• Cutaneous tuberculosis

• Leprosy

• Cutaneous leishmaniasis

• Phaeohyphomycosis

• Verrucous bacterial infections

• Squamous cell carcinoma

Finding sclerotic bodies helps distinguish chromoblastomycosis from other implantation mycoses.

Treatment

Treatment can be difficult, particularly when lesions are large or longstanding. There is no single universally effective regimen.

Management depends largely on lesion size, location, and extent.

Small Lesions

Small, localized lesions may be treated with:

Surgical excision

or

Cryotherapy

Complete removal is most successful when disease is detected early and remains well localized.

Itraconazole

Itraconazole is an important systemic treatment option.

Treatment usually needs to be prolonged:

At least 6 months, and often considerably longer depending on clinical response.

Itraconazole may be combined with:

• Cryotherapy

• Surgical excision

• Other local destructive techniques

Combination therapy can be particularly useful for larger or more persistent lesions.

Terbinafine

Terbinafine is another important systemic antifungal option and may be used alone or as part of combination management.

Extensive or Refractory Disease

For extensive disease, historical treatment approaches have included:

Flucytosine + amphotericin B

More recently, broad-spectrum triazole antifungals may have activity against some causative organisms.

Treatment should ideally be guided by the specific organism, disease severity, and clinical response.

Prevention

Because infection usually follows traumatic implantation, prevention focuses on protecting the skin from contaminated soil and vegetation.

Protective measures include:

• Wearing shoes or boots

• Wearing long trousers and protective clothing

• Wearing gloves during agricultural work

• Promptly cleaning penetrating skin injuries

These precautions reduce exposure to thorns, splinters, and other materials capable of introducing the fungus into subcutaneous tissues.

High-Yield Clinical Pattern

Barefoot agricultural worker in a tropical region

• ●

History of traumatic inoculation

• ●

Slowly progressive verrucous or cauliflower-like lesion on the leg

• ●

Brown sclerotic bodies on histology

→ Think chromoblastomycosis

Key Diagnostic Distinction

Chromoblastomycosis

→ Sclerotic (Medlar/copper-penny) bodies

Phaeohyphomycosis

→ Pigmented hyphae or yeast-like fungal elements in tissue, without characteristic sclerotic bodies

Mycetoma

→ Tumefaction + draining sinus tracts + grains

This distinction is particularly useful in microbiology and infectious disease examinations.

Exam Essentials

Disease: Chromoblastomycosis

Other names: Chromomycosis, dermatitis verrucosa

Organisms: Dematiaceous fungi

Most common species: Fonsecaea pedrosoi

Transmission: Traumatic implantation from soil or vegetation

Typical patient: Rural agricultural worker in a tropical/subtropical region

Typical site: Lower extremities

Typical lesion: Chronic verrucous/warty plaque or nodule

Characteristic tissue finding: Sclerotic bodies

Other names for sclerotic bodies: Medlar bodies, muriform bodies, copper-penny bodies

Diagnosis: Histopathology + fungal culture

Localized treatment: Excision or cryotherapy

Systemic treatment: Prolonged itraconazole or terbinafine

Prevention: Protective shoes and clothing

Key clinical pearl: The combination of a chronic verrucous lower-extremity lesion after traumatic soil or plant exposure and brown copper-penny–like sclerotic bodies in tissue is the classic presentation of chromoblastomycosis.

Infectious Disease and Microbiology – Chromobacterium violaceum

Overview

Chromobacterium violaceum is a rare environmental Gram-negative bacillus that can cause serious human infection after traumatic inoculation or exposure to contaminated water. Although infection is uncommon, it can progress rapidly from a localized wound infection to bacteremia, sepsis, pneumonia, or metastatic abscesses.

Severe disease is especially concerning in patients with chronic granulomatous disease or significant neutrophil dysfunction.

Microbiologic Characteristics

Chromobacterium violaceum is an aerobic Gram-negative bacillus.

Many strains produce a characteristic violet pigment known as violacein, which may give colonies a purple appearance in culture. However, not all strains are pigmented, so absence of violet coloration does not exclude the organism.

Epidemiology

The organism is distributed worldwide, particularly in tropical and subtropical environments.

It is found mainly in:

• Soil

• Fresh water

• Mud

• Natural water sources

Human infection is rare and usually follows environmental exposure.

Transmission

Infection most often occurs when contaminated soil or water enters through a break in the skin.

Typical routes include:

• Traumatic wounds

• Puncture injuries

• Cuts exposed to contaminated water

• Near-drowning or aspiration of contaminated water

The organism can invade locally and then spread hematogenously.

Risk Factors

Important risk factors for severe disease include:

• Chronic granulomatous disease

• Neutropenia

• Other disorders of phagocyte function

• Significant immunosuppression

Patients with chronic granulomatous disease are particularly susceptible because of impaired intracellular killing of certain catalase-positive organisms.

Clinical Infections

Traumatic Wound Infection

Localized infection may develop after environmental contamination of a wound.

Possible findings include:

• Pain

• Erythema

• Swelling

• Purulent drainage

• Cellulitis

• Abscess formation

Because progression can be rapid, patients with systemic symptoms should be assessed for bloodstream spread.

Sepsis

One of the most serious manifestations is bacteremia with sepsis.

Clinical findings may include:

• High fever

• Hypotension

• Tachycardia

• Altered mental status

• Septic shock

• Multiorgan dysfunction

Severe systemic infection is especially important in neutropenic patients and those with chronic granulomatous disease.

Metastatic Abscesses

Hematogenous dissemination may lead to abscess formation in distant organs.

Potential sites include:

• Liver

• Lung

• Spleen

• Brain

• Skin and soft tissues

Persistent fever despite therapy should raise concern for metastatic infection.

Pneumonia

Pneumonia can occur after aspiration of contaminated water, particularly following drowning or near-drowning.

Patients may develop:

• Fever

• Cough

• Dyspnea

• Hypoxemia

• Pulmonary infiltrates

A history of freshwater exposure can provide an important diagnostic clue.

Diagnosis

Diagnosis is established primarily by culture.

Appropriate specimens may include:

• Wound material

• Blood

• Respiratory secretions

• Abscess fluid

• Tissue specimens

The characteristic violet pigmentation, when present, can strongly suggest C. violaceum, but definitive identification requires microbiologic testing.

Treatment

Doxycycline

Doxycycline has activity against C. violaceum and may be useful in susceptible infections.

Fluoroquinolones

Fluoroquinolones, particularly agents such as ciprofloxacin, have historically shown good activity and may be used when susceptibility supports treatment.

Severe Infection

For serious systemic disease, treatment may include a broad-spectrum active agent such as:

• Imipenem

or historically

• A ureidopenicillin in combination with an aminoglycoside

Because antimicrobial susceptibility can vary, severe infection should be treated according to culture and susceptibility results.

Additional Treatment Options

Other agents that may have activity include:

• Trimethoprim-sulfamethoxazole

• Aminoglycosides

Therapy should be individualized based on the infection site, disease severity, and microbiology results.

Source Control

Abscesses and infected wounds may require:

• Surgical drainage

• Debridement

• Removal of devitalized tissue

Source control is especially important in patients with deep or metastatic infection.

Prevention

Prevention includes careful wound protection and avoidance of contamination with untreated freshwater or soil, particularly in high-risk patients.

Important measures include:

• Clean traumatic wounds promptly

• Cover open wounds during freshwater exposure

• Avoid swimming with significant open wounds

• Use particular caution in patients with chronic granulomatous disease

High-Yield Clinical Pattern

Freshwater or soil-contaminated wound

Rapidly progressive infection

Sepsis or metastatic abscesses

→ Think Chromobacterium violaceum

High-Yield Risk Pattern

Patient with chronic granulomatous disease

Severe Gram-negative sepsis after environmental exposure

→ Consider C. violaceum

Exam Essentials

Organism: Chromobacterium violaceum

Microbiology: Aerobic Gram-negative bacillus

Environmental reservoir: Soil and freshwater

Characteristic culture clue: Violet pigment in many strains

Major infections: Wound infection, bacteremia/sepsis, pneumonia

Important complication: Metastatic abscess formation

Major risk factor: Chronic granulomatous disease

Diagnosis: Culture

Commonly active agents: Doxycycline or fluoroquinolones

Severe infection: Carbapenem-based therapy may be appropriate

Additional agents: TMP-SMX or aminoglycosides

Key clinical pearl: A rapidly progressive infection after freshwater or soil exposure, especially in a patient with chronic granulomatous disease, should raise concern for Chromobacterium violaceum.

Infectious Disease and Microbiology – Chlamydophila Species

Overview

Chlamydophila species are obligate intracellular Gram-negative bacteria that primarily cause respiratory infections. The two clinically important organisms are Chlamydophila pneumoniae and Chlamydophila psittaci.

C. pneumoniae is an established cause of community-acquired atypical pneumonia, while C. psittaci causes psittacosis, a zoonotic infection typically acquired from birds.

Important Species

Chlamydophila pneumoniae

C. pneumoniae, historically referred to as TWAR, is transmitted from person to person and causes a proportion of community-acquired respiratory infections.

Chlamydophila psittaci

C. psittaci is associated mainly with birds and causes psittacosis in humans.

Exposure is particularly important among:

• Bird owners

• Poultry workers

• Veterinarians

• Pet-shop employees

• Animal handlers

Microbiologic Characteristics

Chlamydophila species are:

• Gram-negative bacteria

• Obligate intracellular organisms

• Unable to replicate independently outside host cells

Like other chlamydial organisms, they undergo a specialized intracellular developmental cycle.

Epidemiology

C. pneumoniae has a worldwide distribution and spreads primarily through respiratory secretions from person to person.

C. psittaci is maintained in birds and some domestic animals. Humans usually acquire infection by inhaling aerosolized material contaminated with infected bird secretions, respiratory droplets, or dried feces.

Chlamydophila pneumoniae Infection

Respiratory Disease

C. pneumoniae is an important cause of atypical respiratory infection.

Clinical syndromes include:

• Pharyngitis

• Sinusitis

• Bronchitis

• Community-acquired pneumonia

The illness is often gradual in onset.

Patients may develop:

• Low-grade fever

• Headache

• Malaise

• Sore throat

• Hoarseness

• Persistent dry cough

The cough may persist for several weeks even after other symptoms improve.

Pneumonia

Pneumonia caused by C. pneumoniae is usually relatively mild but may occasionally be more significant in older adults or patients with chronic underlying disease.

The presentation may resemble infections caused by:

• Mycoplasma pneumoniae

• Respiratory viruses

• Legionella species

Chlamydophila psittaci Infection

Psittacosis

C. psittaci causes psittacosis, also called ornithosis.

The classic epidemiologic clue is:

Bird exposure + atypical pneumonia

Symptoms may include:

• High fever

• Severe headache

• Myalgias

• Malaise

• Dry cough

• Dyspnea

• Pneumonia

Some patients develop systemic manifestations involving the liver, nervous system, or other organs.

Associated Animals

Birds are the most important reservoirs, particularly:

• Parrots

• Parakeets

• Cockatiels

• Pigeons

• Poultry

Infected birds may appear healthy while shedding the organism.

Possible Association With Atherosclerosis

C. pneumoniae has been investigated as a possible contributor to the development of atherosclerosis.

Although organisms and immune responses have been detected in atherosclerotic tissue, a direct causal role has not been established sufficiently to justify antimicrobial therapy for prevention or treatment of atherosclerosis.

Diagnosis

Diagnosis may be made using:

• PCR

• Serology

• Antigen detection

• Cell culture

Because these organisms are intracellular and difficult to cultivate, molecular and serologic methods are generally more practical than routine culture.

PCR

PCR can detect organism-specific nucleic acid in respiratory specimens.

This provides direct evidence of infection and is especially useful when available.

Serology

Traditional methods include:

• Complement fixation

• Microimmunofluorescence

Microimmunofluorescence has historically been used to distinguish antibody responses to different chlamydial species.

For psittacosis, older diagnostic criteria considered a complement-fixing antibody titer greater than 1:16 supportive in an appropriate clinical setting, although modern diagnostic interpretation generally relies on paired serology or molecular testing.

Antigen Detection

Antigen-detection assays may also identify chlamydial antigens in clinical specimens, although PCR has largely become more useful where available.

Cell Culture

Culture is possible but difficult because the organism requires living cells for replication.

It is mainly performed in specialized or reference laboratories.

Differential Diagnosis

For C. pneumoniae respiratory infection, consider:

• Mycoplasma pneumoniae

• Legionella

• Influenza

• Other respiratory viruses

• Typical bacterial pneumonia

For psittacosis, consider:

• Q fever

• Legionnaires’ disease

• Influenza

• Tularemia

• Other causes of atypical pneumonia

A strong bird-exposure history is particularly helpful for distinguishing psittacosis.

Treatment

Doxycycline

For pneumonia caused by C. pneumoniae, the source regimen is:

Doxycycline 100 mg orally every 12 hours for 10–14 days

Doxycycline is also a major treatment option for psittacosis.

Macrolides

Additional effective agents include:

• Azithromycin

• Clarithromycin

These may be especially useful when tetracyclines are unsuitable.

Tetracycline

Tetracycline-class antibiotics are active against these intracellular organisms and have historically been used extensively for both C. pneumoniae and C. psittaci infections.

Fluoroquinolones

Respiratory fluoroquinolones such as:

• Levofloxacin

may also have activity and can be considered in selected patients.

Prevention

For C. pneumoniae, prevention relies on general respiratory hygiene because infection spreads person to person.

For C. psittaci, prevention includes:

• Proper handling of birds

• Avoiding inhalation of dried bird droppings

• Cleaning cages carefully

• Using protective equipment during high-risk occupational exposure

• Veterinary evaluation of infected birds

High-Yield Clinical Patterns

Chlamydophila pneumoniae

Gradual respiratory illness

• ●

Persistent dry cough

• ●

Community-acquired atypical pneumonia

→ Think C. pneumoniae

Chlamydophila psittaci

Bird exposure

• ●

High fever

• ●

Severe headache

• ●

Atypical pneumonia

→ Think psittacosis

Exam Essentials

Genus: Chlamydophila

Important species:

→ C. pneumoniae

→ C. psittaci

Microbiology:

→ Gram-negative obligate intracellular bacteria

C. pneumoniae transmission:

→ Person to person

C. pneumoniae disease:

→ Community-acquired atypical pneumonia

C. psittaci reservoir:

→ Birds

C. psittaci disease:

→ Psittacosis

Classic psittacosis clue:

→ Bird exposure + atypical pneumonia

Diagnosis:

→ PCR, serology, antigen detection, specialized culture

Treatment:

→ Doxycycline

Other options:

→ Azithromycin, clarithromycin, tetracycline, levofloxacin

Key distinction:

C. pneumoniae → person-to-person respiratory infection

C. psittaci → zoonotic bird-associated pneumonia

Infectious Disease and Microbiology – Chlamydophila Species

Overview

Chlamydophila species are obligate intracellular Gram-negative bacteria that primarily cause respiratory infections. The two clinically important organisms are Chlamydophila pneumoniae and Chlamydophila psittaci.

C. pneumoniae is an established cause of community-acquired atypical pneumonia, while C. psittaci causes psittacosis, a zoonotic infection typically acquired from birds.

Important Species

Chlamydophila pneumoniae

C. pneumoniae, historically referred to as TWAR, is transmitted from person to person and causes a proportion of community-acquired respiratory infections.

Chlamydophila psittaci

C. psittaci is associated mainly with birds and causes psittacosis in humans.

Exposure is particularly important among:

• Bird owners

• Poultry workers

• Veterinarians

• Pet-shop employees

• Animal handlers

Microbiologic Characteristics

Chlamydophila species are:

• Gram-negative bacteria

• Obligate intracellular organisms

• Unable to replicate independently outside host cells

Like other chlamydial organisms, they undergo a specialized intracellular developmental cycle.

Epidemiology

C. pneumoniae has a worldwide distribution and spreads primarily through respiratory secretions from person to person.

C. psittaci is maintained in birds and some domestic animals. Humans usually acquire infection by inhaling aerosolized material contaminated with infected bird secretions, respiratory droplets, or dried feces.

Chlamydophila pneumoniae Infection

Respiratory Disease

C. pneumoniae is an important cause of atypical respiratory infection.

Clinical syndromes include:

• Pharyngitis

• Sinusitis

• Bronchitis

• Community-acquired pneumonia

The illness is often gradual in onset.

Patients may develop:

• Low-grade fever

• Headache

• Malaise

• Sore throat

• Hoarseness

• Persistent dry cough

The cough may persist for several weeks even after other symptoms improve.

Pneumonia

Pneumonia caused by C. pneumoniae is usually relatively mild but may occasionally be more significant in older adults or patients with chronic underlying disease.

The presentation may resemble infections caused by:

• Mycoplasma pneumoniae

• Respiratory viruses

• Legionella species

Chlamydophila psittaci Infection

Psittacosis

C. psittaci causes psittacosis, also called ornithosis.

The classic epidemiologic clue is:

Bird exposure + atypical pneumonia

Symptoms may include:

• High fever

• Severe headache

• Myalgias

• Malaise

• Dry cough

• Dyspnea

• Pneumonia

Some patients develop systemic manifestations involving the liver, nervous system, or other organs.

Associated Animals

Birds are the most important reservoirs, particularly:

• Parrots

• Parakeets

• Cockatiels

• Pigeons

• Poultry

Infected birds may appear healthy while shedding the organism.

Possible Association With Atherosclerosis

C. pneumoniae has been investigated as a possible contributor to the development of atherosclerosis.

Although organisms and immune responses have been detected in atherosclerotic tissue, a direct causal role has not been established sufficiently to justify antimicrobial therapy for prevention or treatment of atherosclerosis.

Diagnosis

Diagnosis may be made using:

• PCR

• Serology

• Antigen detection

• Cell culture

Because these organisms are intracellular and difficult to cultivate, molecular and serologic methods are generally more practical than routine culture.

PCR

PCR can detect organism-specific nucleic acid in respiratory specimens.

This provides direct evidence of infection and is especially useful when available.

Serology

Traditional methods include:

• Complement fixation

• Microimmunofluorescence

Microimmunofluorescence has historically been used to distinguish antibody responses to different chlamydial species.

For psittacosis, older diagnostic criteria considered a complement-fixing antibody titer greater than 1:16 supportive in an appropriate clinical setting, although modern diagnostic interpretation generally relies on paired serology or molecular testing.

Antigen Detection

Antigen-detection assays may also identify chlamydial antigens in clinical specimens, although PCR has largely become more useful where available.

Cell Culture

Culture is possible but difficult because the organism requires living cells for replication.

It is mainly performed in specialized or reference laboratories.

Differential Diagnosis

For C. pneumoniae respiratory infection, consider:

• Mycoplasma pneumoniae

• Legionella

• Influenza

• Other respiratory viruses

• Typical bacterial pneumonia

For psittacosis, consider:

• Q fever

• Legionnaires’ disease

• Influenza

• Tularemia

• Other causes of atypical pneumonia

A strong bird-exposure history is particularly helpful for distinguishing psittacosis.

Treatment

Doxycycline

For pneumonia caused by C. pneumoniae, the source regimen is:

Doxycycline 100 mg orally every 12 hours for 10–14 days

Doxycycline is also a major treatment option for psittacosis.

Macrolides

Additional effective agents include:

• Azithromycin

• Clarithromycin

These may be especially useful when tetracyclines are unsuitable.

Tetracycline

Tetracycline-class antibiotics are active against these intracellular organisms and have historically been used extensively for both C. pneumoniae and C. psittaci infections.

Fluoroquinolones

Respiratory fluoroquinolones such as:

• Levofloxacin

may also have activity and can be considered in selected patients.

Prevention

For C. pneumoniae, prevention relies on general respiratory hygiene because infection spreads person to person.

For C. psittaci, prevention includes:

• Proper handling of birds

• Avoiding inhalation of dried bird droppings

• Cleaning cages carefully

• Using protective equipment during high-risk occupational exposure

• Veterinary evaluation of infected birds

High-Yield Clinical Patterns

Chlamydophila pneumoniae

Gradual respiratory illness

• ●

Persistent dry cough

• ●

Community-acquired atypical pneumonia

→ Think C. pneumoniae

Chlamydophila psittaci

Bird exposure

• ●

High fever

• ●

Severe headache

• ●

Atypical pneumonia

→ Think psittacosis

Exam Essentials

Genus: Chlamydophila

Important species:

→ C. pneumoniae

→ C. psittaci

Microbiology:

→ Gram-negative obligate intracellular bacteria

C. pneumoniae transmission:

→ Person to person

C. pneumoniae disease:

→ Community-acquired atypical pneumonia

C. psittaci reservoir:

→ Birds

C. psittaci disease:

→ Psittacosis

Classic psittacosis clue:

→ Bird exposure + atypical pneumonia

Diagnosis:

→ PCR, serology, antigen detection, specialized culture

Treatment:

→ Doxycycline

Other options:

→ Azithromycin, clarithromycin, tetracycline, levofloxacin

Key distinction:

C. pneumoniae → person-to-person respiratory infection

C. psittaci → zoonotic bird-associated pneumonia

Infectious Disease and Microbiology – Chlamydia trachomatis

Overview

Chlamydia trachomatis is a Gram-negative obligate intracellular bacterium and one of the most important human pathogens in the genus Chlamydia. It causes a wide range of diseases involving the genital tract, rectum, eyes, lymphatic system, and respiratory tract of infants.

It is also a major global cause of preventable blindness through trachoma and is one of the most common bacterial sexually transmitted infections worldwide.

Microbiologic Characteristics

C. trachomatis is an obligate intracellular organism, meaning that it depends on host cells for replication.

Important microbiologic features include:

• Gram-negative bacterial structure

• Obligate intracellular growth

• Formation of intracellular inclusions

• Replication within epithelial cells

Its intracellular life cycle explains why standard bacterial culture methods are not routinely used.

Epidemiology

C. trachomatis infection occurs worldwide.

It is a major cause of sexually transmitted infection and frequently affects sexually active adolescents and young adults.

Trachoma remains an important public-health problem in some endemic regions. Historically, hundreds of millions of people have been affected by ocular infection, with millions developing blindness from repeated inflammation and scarring.

Important Serovars

Different serovars produce different clinical syndromes.

Serovars A, B, Ba, and C are primarily associated with:

→ Trachoma

Serovars D–K are primarily associated with:

→ Urethritis

→ Cervicitis

→ Pelvic inflammatory disease

→ Proctitis

→ Adult conjunctivitis

→ Neonatal conjunctivitis and pneumonia

Serovars L1, L2, and L3 cause:

→ Lymphogranuloma venereum

Anogenital Infection

Genital C. trachomatis infection is often asymptomatic, especially in women.

Clinical manifestations can include:

• Urethritis

• Cervicitis

• Dysuria

• Urethral discharge

• Vaginal discharge

• Postcoital or intermenstrual bleeding

• Pelvic discomfort

Untreated cervical infection may ascend into the upper genital tract and cause pelvic inflammatory disease.

Pelvic Inflammatory Disease

Ascending infection may lead to inflammation of the:

• Endometrium

• Fallopian tubes

• Adjacent pelvic structures

Complications include:

• Tubal scarring

• Infertility

• Ectopic pregnancy

• Chronic pelvic pain

Because many infections are initially asymptomatic, reproductive complications may develop without a clear history of acute disease.

Proctitis

Rectal infection may cause:

• Rectal pain

• Tenesmus

• Mucous or bloody discharge

• Proctitis

Some patients remain asymptomatic.

Conjunctivitis

C. trachomatis can cause conjunctivitis in adults and newborns.

Adult inclusion conjunctivitis may present with:

• Red eye

• Mucopurulent discharge

• Follicular conjunctivitis

• Persistent symptoms despite routine topical antibacterial therapy

Genital infection may be present simultaneously.

Neonatal Conjunctivitis

Infants can acquire C. trachomatis during passage through an infected birth canal.

Conjunctivitis usually develops during the first several weeks of life and may produce:

• Eyelid swelling

• Conjunctival erythema

• Mucopurulent discharge

Systemic therapy is required because respiratory infection may coexist.

Infant Pneumonia

Perinatally acquired infection can cause a characteristic afebrile pneumonia in young infants.

Typical features include:

• Persistent cough

• Tachypnea

• Diffuse pulmonary infiltrates

• Lack of high fever

A classically described pattern is a repetitive staccato cough.

Lymphogranuloma Venereum

Lymphogranuloma venereum, or LGV, is caused by serovars:

L1, L2, and L3

Early infection may begin with a small genital ulcer that can be painless and transient.

This may be followed by:

• Painful regional lymphadenopathy

• Inguinal or femoral buboes

• Proctocolitis

• Fever and systemic symptoms

Rectal LGV can be particularly prominent in certain sexual networks and may mimic inflammatory bowel disease.

Trachoma

Trachoma is a chronic keratoconjunctivitis caused by repeated ocular infection with particular C. trachomatis serovars.

Repeated episodes produce progressive scarring of the conjunctiva.

Over time, eyelid distortion can cause eyelashes to turn inward, a condition known as trichiasis, leading to repeated corneal trauma and eventually blindness.

Diagnosis

Nucleic Acid Amplification Testing

The preferred diagnostic method for most genital infections is a nucleic acid amplification test (NAAT), including PCR-based methods.

Testing can be performed on:

• Urine

• Vaginal specimens

• Cervical specimens

• Urethral specimens

• Rectal specimens when clinically appropriate

NAATs provide excellent sensitivity and specificity.

Antigen Detection

Older diagnostic methods include:

• ELISA antigen detection

• Direct immunofluorescent staining

These approaches have largely been replaced by NAATs in routine practice.

Serology

Serology has limited usefulness for uncomplicated genital infection.

It may provide supportive evidence in invasive syndromes such as lymphogranuloma venereum.

Historically, complement-fixing antibody titers greater than 1:16 have been described in LGV, but modern diagnosis relies more heavily on molecular testing and clinical context.

Cell Culture

Cell culture can identify C. trachomatis, but it is technically demanding and mainly restricted to specialized or reference laboratories.

Cytology and Intracellular Inclusions

Intracytoplasmic inclusions may occasionally be identified in Giemsa-stained epithelial scrapings, particularly from conjunctival specimens.

This is primarily of historical or specialized diagnostic interest rather than routine modern testing.

Treatment

Uncomplicated Urethritis and Cervicitis

Historically, treatment options included:

Azithromycin 1 g orally as a single dose

or

Doxycycline 100 mg orally every 12 hours for 7 days

In current practice, doxycycline is generally favored for uncomplicated chlamydial infection because of particularly good efficacy, including for rectal infection.

Proctitis

For uncomplicated chlamydial proctitis, doxycycline is commonly used.

If lymphogranuloma venereum is suspected, a longer course is required.

Lymphogranuloma Venereum

The standard regimen is:

Doxycycline 100 mg orally every 12 hours for 21 days

This prolonged course is necessary because LGV is an invasive infection involving lymphatic tissues.

Alternative Therapy

Alternative agents have historically included:

• Erythromycin

• Azithromycin in selected situations

Older fluoroquinolone regimens such as ofloxacin or levofloxacin have also been used, but contemporary treatment should follow current sexually transmitted infection guidelines.

Pregnancy

Doxycycline is generally avoided during pregnancy.

Azithromycin is commonly used for chlamydial infection during pregnancy.

Treatment is important because untreated infection increases the risk of maternal complications and neonatal conjunctivitis or pneumonia.

Partner Management

Sex partners should be evaluated and treated when indicated.

Patients should avoid sexual contact until treatment has been completed and partners have been appropriately treated to reduce reinfection.

Follow-Up

Because reinfection is common, repeat testing after treatment is often recommended, particularly in sexually active patients with ongoing risk.

Pregnant patients typically require more specific follow-up, including test-of-cure in accordance with current guidelines.

Prevention

Prevention includes:

• Condom use

• Routine screening of appropriate sexually active populations

• Prompt treatment of infected individuals

• Treatment of sexual partners

• Prenatal screening

• Public-health measures for trachoma control

Trachoma prevention also depends on improved sanitation, facial cleanliness, and reducing transmission in endemic communities.

High-Yield Clinical Patterns

Young sexually active patient + urethritis or cervicitis + negative routine bacterial culture

→ Think Chlamydia trachomatis

Infant + afebrile staccato cough

→ Think chlamydial pneumonia

Genital ulcer followed by painful lymphadenopathy or severe proctocolitis

→ Think lymphogranuloma venereum

Repeated ocular infection + conjunctival scarring + trichiasis

→ Think trachoma

Exam Essentials

Organism: Chlamydia trachomatis

Type: Gram-negative obligate intracellular bacterium

Major STI manifestations: Urethritis, cervicitis, PID, proctitis

LGV serovars: L1, L2, L3

Trachoma serovars: A–C

Genital/ocular/neonatal serovars: D–K

Neonatal infections: Conjunctivitis and afebrile pneumonia

Best routine diagnostic test: NAAT/PCR

Uncomplicated infection treatment: Doxycycline for 7 days is commonly preferred

LGV treatment: Doxycycline for 21 days

Major long-term complication in women: Tubal infertility and ectopic pregnancy

Major ocular complication: Trachoma-related blindness

Key clinical pearl: C. trachomatis is often asymptomatic, so screening and partner treatment are central to preventing pelvic inflammatory disease, infertility, and ongoing transmission.

Infectious Disease and Microbiology – Capnocytophaga Species

Overview

Capnocytophaga species are microaerophilic Gram-negative bacilli that can cause infections after exposure to dogs or cats and can also arise from the normal human oral flora. Some species, especially Capnocytophaga canimorsus, are important because they can cause rapidly progressive sepsis in susceptible patients.

Important species include C. canimorsus, C. cynodegmi, C. gingivalis, C. granulosa, C. haemolytica, C. leadbetteri, C. ochracea, and C. sputigena.

Microbiologic Characteristics

Capnocytophaga organisms are slender Gram-negative bacilli that prefer reduced oxygen conditions. Some species colonize the mouths of dogs and cats, whereas others are part of the normal human oral microbiota.

The organism may sometimes be seen within neutrophils on Gram-stained specimens, which can provide a useful diagnostic clue.

Incubation Period

After animal-associated inoculation, symptoms usually develop within approximately:

1–5 days

Epidemiology and Transmission

Human infection may follow:

• Dog bites

• Cat bites

• Scratches

• Licking of broken skin or wounds

Not all infections require an obvious bite. Saliva contacting damaged skin may be enough to transmit the organism.

Other Capnocytophaga species live normally in the human mouth and may cause oral or systemic infection when host defenses are impaired.

Major Risk Factors

Severe Capnocytophaga infection is especially associated with:

• Asplenia or prior splenectomy

• Alcohol use disorder

• Chronic pulmonary disease

• Neutropenia

• Immunosuppression

Asplenic patients are particularly vulnerable to fulminant bacteremia and septic shock.

Wound Infection

After a dog or cat bite, patients may develop:

• Local pain

• Erythema

• Swelling

• Purulent drainage

• Cellulitis

The infection can remain localized or progress into the bloodstream.

Severe Sepsis

C. canimorsus is particularly notorious for causing rapidly progressive sepsis, sometimes after a seemingly minor dog exposure.

Severe manifestations can include:

• High fever

• Hypotension

• Septic shock

• Disseminated intravascular coagulation

• Purpura

• Multiorgan failure

This presentation is especially important in patients who have undergone splenectomy.

Meningitis

Capnocytophaga can occasionally cause purulent meningitis.

Possible findings include:

• Fever

• Severe headache

• Neck stiffness

• Altered mental status

• CSF pleocytosis

A history of recent animal exposure can be an important clue.

Endocarditis

Rare cases of infective endocarditis may occur, particularly in patients with bacteremia or preexisting cardiac abnormalities.

Possible manifestations include prolonged fever, a new murmur, embolic events, or persistent positive blood cultures.

Septic Arthritis

Joint infection can occur after bacteremia or local inoculation.

Patients may present with:

• Painful swollen joint

• Reduced range of motion

• Fever

• Joint effusion

Oral and Periodontal Disease

Species that are part of normal human oral flora, including C. gingivalis, C. ochracea, and C. sputigena, may contribute to:

• Periodontitis

• Gingival inflammation

• Oral mucositis

These infections are particularly important in neutropenic or immunocompromised patients.

Diagnosis

The main diagnostic method is culture from blood, wound material, cerebrospinal fluid, synovial fluid, or another involved site.

Because these organisms can be fastidious and slow growing, the microbiology laboratory should be alerted when Capnocytophaga is suspected.

A useful microscopy finding is:

Gram-negative bacilli within neutrophils

This may support the diagnosis in a compatible clinical setting.

Treatment

A beta-lactam combined with a beta-lactamase inhibitor is a common treatment approach.

Examples include:

Amoxicillin-clavulanate

or, for more serious infections,

Ampicillin-sulbactam

Third-generation cephalosporins such as ceftriaxone may also be effective.

Severe Infection

For severe bacteremia, meningitis, septic shock, or other invasive disease, options may include:

• Third-generation cephalosporin

• Carbapenem

• Beta-lactam/beta-lactamase inhibitor combination

Therapy should be guided by susceptibility testing whenever possible.

Additional Treatment Options

For milder infections, alternatives may include:

• Clindamycin

• Doxycycline

• Fluoroquinolone

However, treatment should be individualized because resistance patterns vary among species.

Resistance

Some species, particularly C. granulosa and C. haemolytica, may show resistance to beta-lactam antibiotics.

For this reason, susceptibility testing is especially important in invasive infection or when clinical response is poor.

Prevention After Animal Bites

Careful wound cleansing is essential after dog or cat bites.

In patients at very high risk, especially those without a functioning spleen, prophylactic antibiotics may be appropriate.

A commonly used preventive option is:

Amoxicillin-clavulanate

This is particularly relevant after a dog bite in an asplenic patient.

High-Yield Clinical Pattern

Dog bite or dog saliva exposure

• ●

Asplenic patient

• ●

Rapid septic shock and DIC

→ Think Capnocytophaga canimorsus

High-Yield Oral Pattern

Neutropenic patient

• ●

Periodontal or oral mucosal disease

• ●

Gram-negative bacillus from oral flora

→ Consider Capnocytophaga species

Exam Essentials

Genus: Capnocytophaga

Microbiology: Microaerophilic Gram-negative bacillus

Classic species: C. canimorsus

Major exposure: Dog or cat bite, scratch, or lick

Incubation: About 1–5 days

Major risk factors: Asplenia, alcoholism, chronic lung disease, neutropenia

Severe complication: Septic shock with DIC

Other infections: Meningitis, endocarditis, septic arthritis, oral infections

Diagnosis: Culture; Gram-negative bacilli may be seen inside neutrophils

Treatment: Beta-lactam/beta-lactamase inhibitor or third-generation cephalosporin

Other options: Carbapenems, doxycycline, clindamycin, fluoroquinolones

Prevention in high-risk dog bites: Consider amoxicillin-clavulanate

Key clinical pearl: A splenectomized patient who becomes critically ill after a dog bite or even a dog lick to broken skin should immediately raise concern for Capnocytophaga canimorsus.

Infectious Disease and Microbiology – Capillaria Species

Overview

Capillaria species are nematode helminths that can infect different human organ systems depending on the species involved. The three clinically important species are Capillaria philippinensis, Capillaria hepatica, and Capillaria aerophila.

They are associated respectively with intestinal, hepatic, and pulmonary capillariasis.

Microbiologic Characteristics

Capillaria species are parasitic roundworms (nematodes).

Human disease varies according to the tissue tropism of the species:

• C. philippinensis → intestine

• C. hepatica → liver

• C. aerophila → respiratory tract

Epidemiology

Capillaria philippinensis

This species is most strongly associated with:

• The Philippines

• Thailand

Cases outside these endemic regions are uncommon.

Capillaria hepatica

Human infection is rare but has been reported sporadically in multiple countries around the world.

Capillaria aerophila

Human pulmonary infection is very uncommon, with historical cases reported from regions including the former Soviet Union.

Transmission

The route of acquisition depends on the species.

For C. philippinensis, infection is particularly associated with consumption of raw or inadequately cooked fish containing infective larvae.

This dietary exposure is one of the most important clues to intestinal capillariasis.

Intestinal Capillariasis

Capillaria philippinensis causes intestinal capillariasis.

Patients may develop:

• Chronic diarrhea

• Abdominal pain

• Weight loss

• Malabsorption

• Weakness

• Protein loss

Heavy infection can become severe because repeated autoinfection may increase the intestinal parasite burden.

Advanced disease can cause marked nutritional depletion and electrolyte abnormalities.

Hepatic Capillariasis

Capillaria hepatica causes infection of the liver.

Possible manifestations include:

• Fever

• Hepatomegaly

• Abdominal discomfort

• Eosinophilia

• Inflammatory liver disease

The parasite lays eggs within hepatic tissue rather than releasing them normally into the intestinal lumen, so stool testing is generally not useful for this form.

Pulmonary Capillariasis

Capillaria aerophila can infect the respiratory tract.

Possible manifestations include:

• Cough

• Fever

• Dyspnea

• Bronchitic symptoms

• Pulmonary inflammation

Because pulmonary infection is rare and nonspecific, diagnosis may be difficult without parasitologic evidence.

Diagnosis

Intestinal Capillariasis

Diagnosis is made by identifying:

• Eggs

• Larvae

• Occasionally adult parasitic forms

in stool specimens.

Repeated stool examinations may improve diagnostic sensitivity.

Hepatic Capillariasis

Diagnosis generally requires histopathologic examination of liver tissue.

Liver biopsy may demonstrate:

• Characteristic eggs

• Larval or adult worm structures

• Associated inflammatory reaction

Pulmonary Capillariasis

Diagnosis may rely on demonstrating parasitic material in respiratory specimens or tissue, together with an appropriate clinical and epidemiologic setting.

Treatment

Intestinal Capillariasis

The source regimen lists:

Mebendazole 200 mg orally every 12 hours for 20 days

An alternative is:

Albendazole 200 mg orally every 12 hours for 10 days

Treatment should be combined with correction of dehydration, electrolyte disturbance, and nutritional deficiencies when present.

Hepatic Capillariasis

Historically, thiabendazole has been used.

Albendazole is another treatment option.

Because hepatic disease is uncommon, therapy is often individualized according to disease severity and specialist guidance.

Pulmonary Capillariasis

Potential treatment options include:

• Mebendazole

• Albendazole

Clinical response should be monitored carefully because cases are rare and treatment data are limited.

Prevention

Prevention is particularly important for C. philippinensis.

The main measure is:

Avoid eating raw or inadequately cooked fish in endemic areas.

Additional precautions include:

• Thoroughly cooking freshwater fish

• Safe food preparation

• Good sanitation

• Avoiding fecal contamination of food and water

High-Yield Clinical Pattern

Person from the Philippines or Thailand

• ●

Raw fish consumption

• ●

Chronic diarrhea

• ●

Weight loss and malabsorption

→ Think intestinal capillariasis due to Capillaria philippinensis

High-Yield Species Distinction

C. philippinensis

→ Intestinal disease

C. hepatica

→ Hepatic disease

C. aerophila

→ Pulmonary disease

Exam Essentials

Genus: Capillaria

Organism type: Nematode helminth

Important species: C. philippinensis, C. hepatica, C. aerophila

Major geographic clue for C. philippinensis: Philippines and Thailand

Major exposure: Raw or undercooked fish

Intestinal disease: Chronic diarrhea and malabsorption

Hepatic disease: Hepatomegaly and eosinophilic liver inflammation

Pulmonary disease: Respiratory symptoms

Diagnosis of intestinal disease: Eggs or larvae in stool

Diagnosis of hepatic disease: Liver biopsy

Treatment of intestinal disease: Mebendazole or albendazole

Prevention: Avoid raw fish in endemic areas

Key clinical pearl: Capillaria philippinensis should be considered in patients from endemic Asian regions who develop persistent diarrhea and severe malabsorption after eating raw fish.